The external granule layer (EGL) is a proliferative region that produces over 90% of the neurons in the cerebellum but can also malignantly transform into a cerebellar tumor called the medulloblastoma (the most common malignant brain tumor in children). Current dogma considers Hedgehog stimulation a potent proliferative signal for EGL neural progenitor cells (NPCs) and medulloblastomas. However, the Hedgehog pathway also acts as a survival signal in the neural tube where it regulates dorsoventral patterning by controlling NPC apoptosis. Here we show that Hedgehog stimulation is also a potent survival signal in the EGL and medulloblastomas that produces a massive apoptotic response within hours of signal loss in mice. This toxicity can be produced by numerous Hedgehog antagonists (vismodegib, cyclopamine, and jervine) and is Bax/Bak dependent but p53 independent. Finally, since glucocorticoids can also induce EGL and medulloblastoma apoptosis, we show that Hedgehog's effects on apoptosis can occur independent of glucocorticoid stimulation. This effect may play a major role in cerebellar development by directing where EGL proliferation occurs thereby morphologically sculpting growth. It may also be a previously unknown major therapeutic effect of Hedgehog antagonists during medulloblastoma therapy. Results are discussed in terms of their implications for both cerebellar development and medulloblastoma treatment.
Introduction
The external granule layer (EGL) is a proliferative layer producing over 90% of cerebellar neurons which represent over half of the neurons in the entire brain (the cerebellum actually contains more neurons than the cerebrum) (Andersen et al., 1992; Harvey and Napper, 1988) . Once produced, granule neurons migrate past the molecular and Purkinje cell layers before populating the internal granule layer (Fig. 1A) . Since Purkinje cells form synaptic connections with granule neurons, neurogenesis is regulated to maintain a consistent ratio between these cell types (Goldowitz and Hamre, 1998) . A critical factor regulating EGL proliferation is the Sonic Hedgehog (Hh) pathway which begins with the secretion of Sonic Hh ligand from Purkinje cells onto EGL neural progenitor cells (NPCs) where it binds and inhibits the Patched receptor. Since Patched activation normally represses Smoothened, this diminishes inhibition of Smoothened leading to a downstream activation of Gli transcription factors which are thought to potently increase NPC proliferation (Klein et al., 2001; Wechsler-Reya and Scott, 1999) .
There is convincing evidence that EGL NPCs can become tumorinitiating cells that develop into medulloblastomas (MBs), the most common malignant brain tumor in children. For instance, mice with heterozygous mutations in the Patched gene exhibit disrupted inhibition of Smoothened leading to constitutive Hh activation (Goodrich et al., 1997; Oliver et al., 2005) . While the EGL normally disappears by two weeks of age, Patched mice exhibit ectopic preneoplastic EGL remnants that are not a MB but have a high probability of progressing into one. Importantly, similar mutations of the Patched gene spontaneously occur in humans with an analogous increase in MB vulnerability (Oliver et al., 2005) . Consistent with this finding, up to 30% of human MBs are driven by excessive Hh stimulation (Leary and Olson, 2012) . Thus, animal research mirrors clinical findings suggesting that the Hh pathway plays a key role in MB development. This has positioned the Hh pathway as a key area of research for testing MB formation and/or treatment. Much of this interest centers on novel Hedgehog antagonists (HAs) which effectively treat MBs in transgenic mice (Berman et al., 2002; Neurobiology of Disease 83 (2015) [35] [36] [37] [38] [39] [40] [41] [42] [43] 
